Aims We conducted a meta-analysis to evaluate the accuracy of quantitative stress myocardial contrast echocardiography (MCE) in coronary artery disease (CAD). Methods and results Database search was performed through January 2008. We included studies evaluating accuracy of quantitative stress MCE for detection of CAD compared with coronary angiography or single-photon emission computed tomography (SPECT) and measuring reserve parameters of A, b, and Ab. Data from studies were verified and supplemented by the authors of each study. Using random effects meta-analysis, we estimated weighted mean difference (WMD), likelihood ratios (LRs), diagnostic odds ratios (DORs), and summary area under curve (AUC), all with 95% confidence interval (CI). Of 1443 studies, 13 including 627 patients (age range, 38-75 years) and comparing MCE with angiography (n ¼ 10), SPECT (n ¼ 1), or both (n ¼ 2) were eligible. WMD (95% CI) were significantly less in CAD group than no-CAD group: 0.12 (0.06-0.18) (P , 0.001), 1.38 (1.28-1.52) (P , 0.001), and 1.47 (1.18-1.76) (P , 0.001) for A, b, and Ab reserves, respectively. Pooled LRs for positive test were 1.33 (1.13-1.57), 3.76 (2.43-5.80), and 3.64 (2.87-4.78) and LRs for negative test were 0.68 (0.55-0.83), 0.30 (0.24-0.38), and 0.27 (0.22-0.34) for A, b, and Ab reserves, respectively. Pooled DORs were 2.09 (1.42-3.07), 15.11 (7.90-28.91), and 14.73 (9.61-22.57) and ) for A, b, and Ab reserves, respectively. Conclusion Evidence supports the use of quantitative MCE as a non-invasive test for detection of CAD. Standardizing MCE quantification analysis and adherence to reporting standards for diagnostic tests could enhance the quality of evidence in this field.
Introduction
Myocardial contrast echocardiography (MCE) is a rapid, easy-to-perform bedside technique for the assessment of myocardial perfusion. 1 Because of the resemblance between microvascular behaviour of microbubbles and red blood cells, quantification of myocardial blood flow (MBF) can be indirectly, yet accurately calculated using the rate and volume of microbubble movement through the coronary microcirculation. 2 With continuous microbubble infusion, steady-state microbubble concentration is achieved in the blood pool. The replenishment of contrast (after a brief high mechanical index impulse to clear myocardial microbubbles) is characterized by a time-intensity curve, which is subsequently fitted to monoexponential function, Y ¼ A(1 2 e 2bt ), where b represents rate of rise in signal intensity (microbubble velocity) and A is peak plateau of video intensity (myocardial blood volume). The product of A and b represents an index of MBF. [3] [4] [5] Despite the evidence available from well-designed diagnostic accuracy studies on the efficacy of qualitative MCE as a non-invasive technique for the evaluation of myocardial perfusion, little is known about the diagnostic accuracy of quantitative MCE. To address this, we performed a systematic review and meta-analysis to compare MCE quantitative parameters (A, b, and Ab reserves) in patients with and without coronary artery disease (CAD), and evaluated the accuracy of these parameters for the detection of CAD during pharmacologic stress echocardiography, as validated by coronary angiography, nuclear imaging or both.
Methods
Our systematic review and meta-analysis were reported adhering to the standards of the proposal for reporting in accordance with the Meta-analysis of Observational Studies in Epidemiology recommendation, the Standards for Reporting of Diagnostic Accuracy initiatives, and the guidelines for conducting systematic reviews of diagnostic studies. [6] [7] [8] 
Eligibility criteria
We included peer-reviewed studies that assessed the diagnostic accuracy of quantitative MCE (index test) in the evaluation of myocardial perfusion during pharmacologic (vasodilator or dobutamine hydrochloride) stress echocardiography for assessment of CAD in patients with known or suspected CAD. We selected human studies that included coronary angiography or nuclear imaging [singlephoton emission computed tomography (SPECT) or positron emission tomography (PET)], or both as the reference test. Studies that involved patients who presented with acute coronary syndromes were excluded. Studies that did not include quantification of MCE were also excluded. No language restriction was applied.
Search strategy
Literature search was performed by an expert librarian (P.J.E.) on MEDLINE, EMBASE, Cochrane Database of Systematic Reviews, Web of Science, Scopus, DARE, and CENTRAL (from database inception to January 2008). The search terms used were the following: MCE, stress echocardiography testing, nuclear cardiac imaging (SPECT and PET), and coronary angiography. Two reviewers (S.S.A. and A.D.) independently screened the titles and abstracts of all identified reports.
The full published reports of all abstracts selected by the reviewers were retrieved, and a second-step selection based on the inclusion criteria was performed by the same two reviewers independently. At both stages of selection, we estimated chance-adjusted agreement statistics (i.e. k-statistic); disagreements were resolved by consensus. 9 In addition, one reviewer (S.S.A.) manually reviewed the bibliographies of retrieved articles for additional citations.
Methodological quality evaluation
For each candidate study, two reviewers (S.S.A. and A.D.) independently assessed the methodological quality using the Quality Assessment of Diagnostic Accuracy Studies tool. 10 The tool includes 14 questions in three domains (generalizability, clarity, and validity; Appendix 1). Disagreements were resolved by consensus, and agreement between the two reviewers was measured by k-statistics.
Data collection
A standardized data extraction sheet was developed, and two reviewers (S.S.A. and A.D.) independently extracted data from each included report. Extracted data included: mean age of patients, sex distribution, number of healthy volunteers in the study, and the numbers of patients with a previous history of CAD, prior coronary revascularization (percutaneous or surgical), and previous acute myocardial infarction. We extracted measurements of quantitative MCE, including A, b, and Ab reserves of patients with CAD and those without CAD. We also extracted the sensitivity and specificity and their cut-offs. Disagreements between the two reviewers were resolved by consensus. Authors [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] were contacted to provide individual patient data, which were used to complete missing information.
Outcomes of interest
The mean estimates for MCE reserve (stress/rest) parameters, including A, b, and Ab reserves, were reported in patients with and without CAD on the basis of a reference test. For the evaluation of the diagnostic accuracy of quantitative MCE, diagnostic odds ratio (DOR) was the primary endpoint. Others included positive and negative likelihood ratios (LRþ and LR2), and summary receiver-operator characteristic (SROC) curve of the quantitative MCE. LR is defined as the probability of a given level of a test result for patients with the disease divided by the probability of that same result for patients without the disease. The LR of a positive test (LRþ) equals sensitivity/(1 2 specificity); the LR of a negative test (LR2) equals (1 2 sensitivity)/specificity. DOR describes the odds of a positive test in a patient with the disease (CAD) compared with the odds of a patient without the disease and equals LRþ/LR2. 27 
Statistical analysis
A priori, we decided that the included studies would be heterogeneous and chose the random-effect model 28 for all pooled analysis. Using this model, we estimated the pooled weighted mean differences (WMDs) in the quantitative MCE parameters between patients with CAD and those without CAD. We avoided pooling sensitivity and specificity separately because such analyses ignore their inter-relationship. Thus, the primary endpoint for evaluation of the diagnostic accuracy of quantitative MCE was the pooled DOR. If zero counts occurred for study data, a continuity correction of 0.5 was added to every cell. Other endpoints for evaluation of diagnostic accuracy included LRþ, and LR2. Finally, Moses linear models were used to draw the SROC curve, with each study represented as a point on the graph. 29 In these analyses, we inspected the data for inconsistency in results across studies and used the I 2 statistic to assess inconsistency. The I 2 statistic estimates the percentage of variability in results across studies explained with true differences in patients, tests, outcomes, and design rather than owing to chance, with values of 25%, 50%, and 75% indicating low, moderate, and high inconsistency, respectively.
Subgroup analyses were planned a priori to explain potential heterogeneity among studies postulating subgroup accuracy 
Results

Study selection and characteristics
Of 1443 studies retrieved through the primary search, 14 studies met the inclusion criteria. Agreement between the two reviewers in the final selection of studies was 96%, with a k-statistic of 0.88 [standard error, 0.068; 95% confidence interval (CI), 0.746-1.012]. Two additional studies were identified from the bibliography search, and authors of the 16 studies [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] were contacted to verify inclusion. After the exclusion of two studies that performed MCE quantification only at rest 18 and did not include quantification of parametric MCE, 19 14 reports of 13 studies were eligible ( Figure 1 ). These 13 studies involved 627 patients with quantitative MCE analysis successfully performed for 574 (92%) patients. [11] [12] [13] [14] 16, 17, [20] [21] [22] [23] [24] [25] [26] Reference test in the selected studies included coronary angiography in 10, SPECT in one, and both in two. PET was performed in one study 12 that had a comparison coronary angiography as the reference test, so we included coronary angiography as the reference test for that study. The baseline characteristics and quality evaluation of the included studies are presented in Tables 1 and 2 . The agreement between the two reviewers in quality evaluation of the included studies was 98% of the questions evaluated, with an overall k-statistic of 0.91 and a range of 0.63-1.0. All of the 16 authors contacted replied to our queries, and 13 unique reports were included. Finally, nine authors provided their individual patient data. [12] [13] [14] 17, 20, 21, [23] [24] [25] [26] The different cut-offs for coronary artery stenosis based on the reference test and quantitative MCE parameters utilized to detect CAD are shown in the Supplementary data online, file 1.
Comparison between coronary artery disease and no-coronary artery disease groups
Data for evaluation of A reserve were complete for 11 reports, 12-14,17,20-26 whereas for b and Ab reserves, data were complete for 12 reports. [12] [13] [14] 16, 17, [20] [21] [22] [23] [24] [25] [26] A, b, and Ab reserves were significantly less in the CAD group than in the no-CAD group [WMD 0.12 (95% CI, 0.06-0.18; P , 0.001), 1.38 (95% CI, 1.28-1.52; P , 0.001), and 1.47 (95% CI, 1.18-1.76; P , 0.001), respectively; Figure 2 ]. Significant heterogeneity was observed among studies in the reported b and Ab reserves [I 2 , 44% (P ¼ 0.05) and 75% (P , 0.001), respectively]. To explore heterogeneity in b and Ab reserves, we conducted planned subgroup analyses, finding larger differences in the levels of Ab reserve between patients with and without CAD when patients had a history of acute myocardial infarction or coronary artery bypass graft ( Table 3 ).
The diagnostic accuracy of quantitative myocardial echocardiography
Sensitivity and specificity for A reserve were available in nine reports, [12] [13] [14] [21] [22] [23] [24] [25] [26] and b and Ab reserves were available in all 13 reports. [11] [12] [13] [14] 16, 17, [20] [21] [22] [23] [24] [25] [26] The pooled LRs for a positive test were 1.33 (95% CI, 1.13-1.57), 3.76 (95% CI, 2.43-5.80), The study included a group of CAD patients and healthy volunteers. Data from the healthy volunteers group were not included in the meta-analysis. Peltier et al. 16 Guo et al. 21 Moir et al.
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11
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Generalizability Q1: reserve, and 0.859 (95% CI, 0.842-8.750) for Ab reserve ( Figure 5 ). Substantial heterogeneity in LRþ, LR2, and DOR was detected for pooled estimates of b and Ab reserves (Figures 3 and 4) . To explore other sources for heterogeneity in b and Ab reserves, we conducted subgroup analyses for diagnostic accuracy endpoints. Interaction was only detected among the subgroups of Ab reserve ( Table 4) . With further exploration of this finding, analysis showed significant association between the type of contrast agent used (P ¼ 0.01), type of analysis (P ¼ 0.05), and the cut-off level (P ¼ 0.03) with the pooled DOR for Ab reserve. However, none of those variables was an independent predictor of the diagnostic accuracy of the test.
Sensitivity analyses
The sensitivity analysis performed by using fixed-effects model yielded similar results in the three endpoints. Sensitivity analyses with the high mechanical index in the study by Dawson et al. 23 and another with adenosine stress instead of dobutamine stress in the report by Kowatsch et al. 25 did not change the pooled estimates. Furthermore, sensitivity analysis performed for each type of reference test (Supplementary data online, file 2a and b), for the presence or absence of prior myocardial infarction (Supplementary data online, file 3a and b), for the level of analysis either on patient level, or segmental, or territorial level of analysis (Supplementary data online, file 4a and b), and for type of pharmacological stress (Supplementary data online, file 5a and b) used did not change the overall pooled estimates (WMD or DOR). Finally, sensitivity analysis excluding data obtained from individual patient information sent by the authors [12] [13] [14] 17, 20, 21, [23] [24] [25] was performed. However, the overall pooled estimates did not significantly change after exclusion of these data. We have also included the Sensitivity and specificity displays for each study as shown in Supplementary data online, file 6.
Discussion
The current systematic review and meta-analysis confirms evidence for the application of the technique of quantitative MCE to diagnose CAD. The ability of quantitative MCE parameters to differentiate patients with CAD from those with no-CAD was evident for all measures. Reserves of A, b, and Ab were significantly less in the CAD group than in the no-CAD group. Both b and Ab reserves had comparably A, peak plateau signal intensity, reflective of myocardial capillary blood volume; Ab, myocardial blood flow; AMI, acute myocardial infarction; b, rate of signal intensity rise, reflective of myocardial blood flow velocity; CABG, coronary artery bypass graft; CI, confidence interval; SPECT, single-photon emission computed tomography; WMD, weighted mean difference. a WMD is the pooled mean change across studies between the reported estimates of patients with CAD and patients without CAD. acceptable diagnostic accuracy, had significantly higher LRþ (3.76 and 3.64) than A reserve (1.33), and had significantly lower LR2 (0.30 and 0.27) than A reserve (0.68). In addition, b and Ab reserves had higher pooled DOR and overall larger AUC than A reserve. 'A' represents the peak plateau signal intensity, reflecting myocardial capillary blood volume. Despite less heterogeneity in the A parameter, the low diagnostic accuracy reflected by the lower DOR (2.09) indicates an overlap of the A parameter in the CAD and no-CAD groups. In addition, methods differed in whether A was reported using normalization or correction for ultrasound inhomogeneity, limiting the possibility of standardization of the method for its report and interpretation. All these factors limit the diagnostic accuracy of A reserve alone. This observation is in agreement with previous studies reporting that A values correlated poorly with flow measurements taken with radiolabelled red blood cell microspheres or intracoronary Doppler flow wire, or both. 32, 33 b is the rate of signal intensity rise and reflects microbubble velocity, and Ab reflects MBF. The diagnostic accuracy measures for these two perfusion parameters showed reasonable diagnostic performance in the differentiation between patients with CAD and those without CAD. The diagnostic accuracy measures of b and Ab reserves were significantly better than those of A reserve. Both b and Ab reserves had acceptable pooled DORs of 15.11 and 14.73 and estimated AUCs of 0.850 and 0.859, respectively.
To further illustrate these findings, we used the Fagan nomogram 31 to test a hypothetical patient with a pretest probability of 50% ( Figure 6 ). If this patient had LRs of a positive Ab reserve of 3.64, there would be a post-test probability of 80% of CAD. If this same patient had LRs of a negative Ab reserve of 0.27, the post-test probability would be decreased to 20-25%. This result may demonstrate the clinical relevance of MCE testing for detection of CAD in patients with different pretest probabilities. Methodological heterogeneity, along with the absence of widely validated universal cut-offs, precludes drawing strong inferences from the available data to support the immediate use of quantitative MCE in clinical settings. Other methodological issues that could explain the heterogeneity among studies include: (1) the variability in image quality inherent in using different ultrasound systems equipped with unique contrast capable settings and (2) the learning curve for quantitative analysis. Further recent advancements in ultrasound system technology to optimize contrast perfusion detection will likely decrease this variability in the technical quality of the imaging. However, the learning curve and the experience needed to accurately perform and analyse contrast One subgroup analysis showed significant interaction in the comparison between patients with CAD and patients without CAD (i.e. history of acute myocardial infarction, coronary artery bypass graft, or percutaneous coronary intervention). This interaction can be explained by the marked observed differences between normal and abnormal myocardium in patients with previous heart disease. For diagnostic accuracy studies, only two variables (cut-offs of Ab reserve and the type of contrast agent) could significantly predict accuracy, which indicated the possible roles of these two factors in improving the diagnostic accuracy of quantitative MCE. These results call for more effort to standardize the methods and interpretation of quantitative MCE to increase test reliability and reproducibility, and enable its integration into clinical practice.
Limitations and strengths
This systematic review was limited by the constraints of the published data, especially the variability of the methods reported for calculation of quantitative parameters among the different research groups, the use of different contrast agents, the presence of different levels of comparison (patient level and territorial level), the different stress tests, different cut-offs for CAD or for quantitative MCE parameters, different imaging MCE methodology (high mechanical index intermittent imaging vs. low mechanical index continuous "real-time" imaging), and different reference tests used. These methodological differences likely resulted in the observed heterogeneity among the measures reported in different studies. In an effort to explore those sources of heterogeneity, we planned and performed several subgroup analyses on the basis of these variables. In addition, we performed sensitivity analysis and none of these variables resulted in a change in the overall pooled estimates. Another important limitation of the included studies is the incomplete and inconsistent reporting of all three quantitative measures (A, b, and Ab) at rest and at stress. This incomplete reporting precluded the evaluation of diagnostic accuracy and might limit the external validity of the results. In addition, we have highlighted the use of MCE quantification only for confirmation or exclusion of CAD and we did not include the quantification of the ischaemic myocardium. We also did not compare the use of qualitative vs. quantitative MCE in this meta-analysis, as the main aim of this review was to report on the diagnostic accuracy of quantitative MCE parameters in the detection of CAD. Future meta-analysis comparing both qualitative and quantitative MCE is highly recommended.
Strengths of our review include the focused nature of the review question, the comprehensive search strategy, the reproducible judgments for inclusion of studies and assessment of their methodological quality, duplicate data extraction, and parsimonious analyses, including subgroup analyses to understand inconsistencies and sensitivity analyses to evaluate the robustness of our findings to variations in review assumptions. Furthermore, to overcome the limitations of the published record of the eligible studies, we contacted the authors of those included studies, who kindly provided confirmation of eligibility, verification of extracted data, and missing data.
External validity, clinical implications, and future research
The patients included in this review had a wide range of prevalence of CAD from 17% to 71%. This prevalence was mainly because the authors of most of the included studies performed the technique for patients who were already referred for angiography, to increase accessibility to larger samples. Nevertheless, when we compared the DOR in studies with ,50% prevalence of CAD with that in studies with 50% or greater prevalence of CAD, there was no significant difference in the DOR between the two groups. Future studies evaluating patients who have a lower risk of CAD would be important to support these data.
Existing data support a moderate diagnostic accuracy of quantitative MCE in the detection of CAD in patients with known or suspected CAD. However, standardization of the A, peak plateau signal intensity, reflective of myocardial capillary blood volume; Ab, myocardial blood flow; AMI, acute myocardial infarction; b, rate of signal intensity rise, reflective of myocardial blood flow velocity; CABG, coronary artery bypass graft; CAD, coronary artery disease; DOR, diagnostic odds ratio; NA, not available; SPECT, single-photon emission computed tomography. a Heterogeneity testing is a statistical test for variability among the reported DOR in the studies included in a meta-analysis. methods used for conduct, analysis, interpretation, and reporting of those measures is needed to facilitate clinical implementation of the quantitative MCE technique. A large multicentre study of sufficient sample size to provide valid and reliable cut-offs, composed of a broder spectrum of patients with acute and chronic CAD and using standardized protocols for imaging, data analysis, and interpretation, would be of great benefit for optimized clinical application of this technique in order to minimize the potential for heterogeneity as observed in the evaluated studies.
Supplementary data
Supplementary data are available at European Journal of Echocardiography online. Were withdrawals from the study explained? (Clarity) Figure 6 The post-test probability based on 50% pretest probability of coronary artery disease and the pooled estimates for likelihood ratios (LRs) for a positive (LRþ) and negative (LR2) test for Ab reserve with Fagan nomogram. Ab indicates myocardial blood flow.
